ORPHA:96123
Monosomy 22 syndrome
Also known as: Del(22) · Deletion 22
Publications
1,632
Trials
0
Interventional, condition-specific
Researchers
1,539
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare anomaly syndrome, with a highly variable , typically characterized by short length, joint abnormalities (e.g. , hyperextensibility, contractures, dislocation), cardiac defects, and craniofacial dysmorphism (incl. microcephaly, a high, prominent, narrow and/or hairy forehead, epicanthus, upward-slanting and/or small palpebral fissures, broad, high or depressed nasal bridge and malformed ears). Delayed motor development and is observed in patients not presenting early demise.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019891
- UMLS:C0795878
- NCIT:C36461
Additional Mondo synonyms (2)
deletion 22 · monosomy type 22
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,632 matched papers (1,000 in last 10 years) Source
- Phenotype characterisedPresent
40 HPO annotations (e.g. Posteriorly rotated ears; Retrognathia; Single transverse palmar crease) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 6 for broader category monosomy
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
40
Associated phenotypes · MONDO:0019891
- Posteriorly rotated ears
- Retrognathia
- Single transverse palmar crease
- Intellectual disability
- Meningioma
Showing 5 of 40 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,632
1,632 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,632 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,000 in the last 10 years · low confidence
Phrase hits: 1,632 · MeSH hits: 0
Who's working on it?
1,539
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Kantelhardt EJ21 papers · 2026
Global and Planetary Health Working Group, Institute of Medical Epidemiology, Biometrics, and Informatics, Center of Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, Halle (Saale), 06112, Germany.
Papers in Europe PMC - 02Addissie A15 papers · 2026
Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Papers in Europe PMC - 03Gizaw M12 papers · 2026
Global and Planetary Health Working Group, Institute of Medical Epidemiology, Biometrics, and Informatics, Center of Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, Halle (Saale), 06112, Germany.
Papers in Europe PMC - 04Bonfoh B11 papers · 2026
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Papers in Europe PMC - 05Getachew S10 papers · 2026
Global and Planetary Health Working Group, Institute of Medical Epidemiology, Biometrics, and Informatics, Center of Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, Halle (Saale), 06112, Germany.
Papers in Europe PMC - 06Mremi A10 papers · 2025
Faculty of Medicine, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania.
Papers in Europe PMC - 07Kroeber ES9 papers · 2026
Global and Planetary Health Working Group, Institute of Medical Epidemiology, Biometrics, and Informatics, Center of Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, Halle (Saale), 06112, Germany.
Papers in Europe PMC - 08Ndung'u T9 papers · 2026
HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Papers in Europe PMC - 09Destaw A8 papers · 2026
Global and Planetary Health Working Group, Institute of Medical Epidemiology, Biometrics, and Informatics, Center of Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, Halle (Saale), 06112, Germany.
Papers in Europe PMC - 10Bosomprah S7 papers · 2026
Research Division, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 6 trials are registered for monosomy, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
6 interventional trials matched monosomy, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: monosomy
6
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT05735717·RECRUITING·MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Conditions: Hematologic Malignancy · Acute Leukemia · Remission · Acute Myeloid Leukemia·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 15 · after dedupe 15 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 15 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (15)
- isrctn·ISRCTN70717445·Recruiting·A clinical trial testing vaccines designed to prevent lung cancer in people at risk of recurrent or new lung cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN23678136·Recruiting·Enhancing care for delirium in palliative care units
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13390479·Recruiting·The neurocognitive benefits of proton beam therapy for patients with oligodendroglioma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11527992·No longer recruiting·A phase 2, open-label, parallel cohort study of subcutaneous amivantamab in multiple regimens in patients with advanced or metastatic solid tumors including EGFR-mutated non-small cell lung cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN77394655·No longer recruiting·Study to determine the preventive effect of denosumab on breast cancer in women carrying a BRCA1 germline mutation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN99682126·No longer recruiting·Phase 1b dose escalation and dose expansion study in patients with advanced or metastatic non-small cell lung cancer (NSCLC)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11652897·No longer recruiting·Study to determine the effectiveness and safety of DNL310 vs idursulfase in pediatric participants with neuronopathic or non-neuronopathic Hunter Syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16889608·No longer recruiting·Genetic biomarkers for retinopathy of prematurity
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16052954·No longer recruiting·The survival benefits of re-irradiation and chemotherapy for patients with relapsed glioblastoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11312093·No longer recruiting·Brain health in retired athletes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65011803·No longer recruiting·Effects of tamoxifen in patients with myeloproliferatIve disorders
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13751862·No longer recruiting·Assessment of venetoclax in combination with Ibrutinib in patients with Chronic Lymphocytic Leukaemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN01844152·No longer recruiting·Front-line therapy in CLL: assessment of ibrutinib-containing regimes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12695354·No longer recruiting·IciCLLe: Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN40303610·No longer recruiting·Phase II trial of alemtuzumab, dexamethasone and lenalidomide followed by randomisation to lenalidomide maintenance versus no further treatment for high-risk CLL NCRI CLL210)
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Monosomy 22 syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Monosomy 22 syndrome" OR "Del(22)" OR "Deletion 22" OR "monosomy type 22"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Monosomy 22 syndrome" OR "Del(22)" OR "Deletion 22" OR "monosomy type 22"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"monosomy"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1632) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T04:54:01.071Z
